Repligen (RGEN) PT Raised to $210 at HSBC

September 1, 2026 2:16 AM

HSBC analyst Shubhangi Gupta raised the price target on Repligen (NASDAQ: RGEN) to $210.00 (from $170.00) while maintaining a Buy rating.

No results found